CRDF

Cardiff Oncology, Inc.

Contracts

Total Value

Stock Metrics

18.3%

Short % Float

9.3d to cover · Moderate squeeze

22.8%

Inst % Float

10 holders · 2026-06-30

Laurion Capital Ma

Top Holder

4.0% of float

66.7M sh

Public Float

40/100

Dilution Score

Medium

13 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

40/100

MEDIUM

Inst: 22.83% · Top: Laurion Capital Management, LP

Biotech Analytics

Oncology

38.41

Squeeze risk: MODERATEBiotech Grade: D

Insider Buying0

Publications100

Dilution Risk40

Clinical Trials58

Short Interest50